Boston
Our Board of Advisors, all industry leaders, have made a powerful statement by supporting Life Science Cares and our goal to end poverty in our community. Annually, our Advisors make a personal financial contribution to cover LSC’s administrative costs, allowing us to channel money raised from our event fundraisers, Corporate Membership Program, and from individuals to our partner organizations.
Our Board of Advisor members also choose to volunteer with their companies and recruit their colleagues to join in this collective effort.
Rich Aldrich
General Partner
Longwood Fund
Stephane Bancel
CEO
Moderna Therapeutics
Mark Bamforth
Founder
Thairm Bio
Imran Babar
Chief Business & Financial Officer
Sudo Biosciences
Peter Barrett
Partner
Atlas Venture
Jeff Albers
Venture Partner
Atlas Venture
Mitch Bloom
Partner
Goodwin
Joshua Boger
Foundation & CEO (Former)
Vertex Pharmaceuticals
Bruce Booth
Partner
Atlas Venture
Katrine Bosley
Founding CEO
DaCapo Brainscience
Michael Broxson
Principal
Tennyson Advisory
Paul Burgess
Chief Operating Officer and Chief Business Officer
Kailera Therapeutics
Thomas Carey
Founder & Partner
Perspective Group
Bharatt Chowrira
CEO & Board Member
PureTech Health
Tim Clackson
President and CEO
IDRx
Ron Cooper
Global CEO | Board Chair & Director
Zoltan Csimma
Senior Biotech Executive
Elisabet De los Pinos
CEO
Aura Biosciences
Dee Dee DeMan
Chairman & CEO
Bench International
Tom DesRosier
Executive Vice President & Chief Legal Officer
Seres Therapeutics
Steven Dickman
Owner
CBT Advisors
Wendy Erler
VP, Head of STAR Patient Insights & Advocacy
Astra Zeneca, Alexion Rare Disease
Greg Erman
Member
Mass Medical Angels
Douglas Fambrough
Managing Partner
KCap Biotechnology Fund
James Foster
Chairman, President & CEO
Charles River Labs
Jean George
General Partner
Lightstone Ventures
Jeff Goater
Venture Partner
The Column Group
Brian Goff
Chief Commercial and Global Operations Officer
Alexion
Dave Grayzel
Partner
Atlas Venture
Penny Heaton
Global Therapeutic Head, Vaccines
Janssen
Michael Heffernan
Chairman
Collegium Pharmaceuticals
Jeffrey Hemman
Partner
PWC
Bruce Jacobs
Chief Financial Officer
Kymera Therapeutics
Ed Kaye, MD
CEO & Director
Stoke Therapeutics
Adam Koppel
Managing Director
Bain Capital Life Sciences
Nerissa Kreher
Founder
Mountainview Clinical Development Consulting
Michel Lagarde
Chief Operating Officer
Thermo Fisher
Donna Lavoie
CEO
LavoieHealthScience
Mark Levin
Partner
Third Rock Ventures
Ankit Mahadevia
Chairman
Spero Therapeutics
David Meeker
President & CEO
Rhythm Pharmaceuticals
Dave Mello
President
The Richmond Group
Jill Milne
CEO
Astria Therapeutics
Ted Myles
Chief Operating Officer & Chief Financial Officer
Scholar Rock
Susan Nemetz
Founder & CEO
The NemetzGroup
Leslie Orne
President & CEO
Trinity Life Sciences
Paula Ragan
CEO & President
X4 Pharmaceuticals
Jigar Raythatha
Partner
Third Rock Ventures
Laurence Reid
Director
Garuda Therapeutics
Jason Rhodes
Partner
Atlas Venture
Alicia Secor
President & CEO
Atalanta Therapeutics
Eric Shaff
President & CEO
Seres Therapeutics
Bill Sibold
CEO
Madrigal Pharmaceuticals
Nancy Simonian
Biotech Executive & Board Member
Otello Stampacchia
Founder
Omega Funds
Mary Thistle
Director
Rajeev Venkayya
CEO
Aerium Therapeutics
Shelia Violette
Co-Founder, Chief Scientific Officer & President of Research
Q32 Bio
Christoph Westphal
General Partner
Longwood Fund
Marc Beer
Executive Chairman
BioTE
Kevin Bitterman
Partner
Atlas Venture
Pablo Cagnoni
President and Head of R&D
Incyte
Abbie Celniker
Partner
Third Rock Ventures
Hugh Cole
Board Member
Astria Therapeutics
Neal Dunn
Partner
Trinity
Paul Enderle
Managing Director
Baycross Capital Group
Elan Ezickson
Biotech Board Member
Joe Farmer
President and Chief Operating Officer
Zenas BioPharma
Chris Gabrieli
Biotech VC (Retired)
Nick Galakatos
Global Head
Blackstone Life Sciences
Halley Gilbert
Chief Legal Officer Chief Legal Officer
CARGO Therapeutics
Glen Giovannetti
Global Biotechnology Leader (Retired)
EY
John Glasspool
Venture Partner
Agent Capital
Mike Gray
Chief Financial and Chief Operating Officer
Upstream Bio
Chris Guiffre
President & COO
Auron Therapeutics
Bill Heiden
Healthcare Executive & Board Member
Colin Hill
CEO, Chairman & Co-Founder
Aitia
Andrew Hirsch
CEO
C4 Therapeutics
Tim Hunt
CEO
Alliance for Regenerative Medicine
Doug Ingram
CEO
Sarepta
Pierre Jacquet
Managing Director & Partner
L.E.K. Consulting
Brian Johnson
President
MassMEDIC
Rosanna Kapeller
President & CEO
Rome Therapeutics
Jason Kelly
CEO
Ginkgo Bio
Richard Kertzman
Sr. Managing Director
Citizens
Iya Khalil
Vice President and Head of Data, A.I. & Genome Sciences
Merck
Bjorn Koch
Senior Vice President, Wealth Management
UBS
Joanne Kotz
President & CEO
Jnana Therapeutics
Peter Latham
CEO
Latham Biopharma Group
Mike Bonney
Biotech Executive & Board Member
Jeff Leerink
CEO
SVB Leerink
Jeff Leiden
Executive Chairman
Vertex Pharmaceuticals
Daniel Lynch
Chairman
bluebird bio
Ivana Magovcevic-Liebisch
President & CEO
Vigil Neuroscience
Eddie Martucci
Chair of the Board
Akili Interactive
Katie McCarthy
Managing Director
Halloran Consulting Group
Geoffrey McDonough
President & CEO
Generation Bio
Bill McVicar
Principal Consultant
BioStrat Consulting
Cherie Myatt
President
OPEN Health Patient Engagement
Marian Nakada
Vice President, Venture Investments
J&J
Amir Nashat
Partner
Polaris Partners
Mike O'Hara
Partner
Deloitte
Douglas Pagan
Chief Financial Officer & Chief Operating Office
Jnana Therapeutics
Paris Panayiotopoulos
Partner and member of the Investment Committee
The Blackstone Group
Deval Patrick
Founder & Chairman
TogetherFUND
Rene Russo
CEO
Xilio Therapeutics
Nabiha Saklayen
Co-Founder & CEO
Cellino Biotech
Ian Sanderson
Chief Financial Officer
Nimbus Pharmaceuticals
Mike Tomsicek
Biotech Board Member
Samantha Truex
Biotech Board Member
Joseph Vittiglio
Chief Legal & Business Officer
bluebird bio
Joe vonRickenbach
Biotech Board Member
Leslie Williams
Co-Founder, President & CEO
hC Bioscience
Cissy Young
Partner
Catalyst Advisors
Hilary Malone
CEO
NewCo
Michael Gilman
CEO
Arrakis Therapeutics
Tracey Sacco
Chief Commercial Officer
Scholar Rock
Skip Kelly
Managing Director
JP Morgan
Kate Walsh
Managing Director, Life Science & Healthcare
HSBC Innovation Banking
Arjun Goyal
Co-Founder and Managing Director
Vida Ventures
Stefan Vitorovic
Co-Founder and Managing Director
Vida Ventures
Jo Viney
CEO
Seismic Therapeutics
Steven Tregay
Managing Partner
Mission Bio Capital
Marnie Hoolahan
President
The Nemetz Group
Doug Kerr
Venture Partner
Atlas Venture
Melissa Manno
Chief Human Resources Officer
Viridian Therapeutics
Joshua Philbrook
President
DENS Facility Services
Alice Pomponio
Managing Director
BrightEdge at American Cancer Society
Art Krieg
Founder, President, and acting CEO/CSO
Zola Therapeutics
Kara Coluccio
Consultant, Biopharma and Board Practices
Spencer Stuart
Ram Aiyar
CEO
Korro Bio
Matt Henn
EVP, Chief Scientific Officer
Seres Therapeutics
Samantha Singer
President & CEO
Abata Therapeutics
Ramani Varanasi
Managing Director
Revive Advisors
Alex Harding
Entrepreneur in Residence
Atlas Venture
Michael Gladstone
Partner
Atlas Venture
Dr. Phil Sharp
Nova Diop
SVP & Co-Chair Diversity, Equity & Inclusion Executive Recruitment
Bench International
Andy Beck
CEO
PathAI
Dipal Doshi
President & CEO
Entrada Therapeutics
Paul Biondi
President
Pioneering Medicines
Mike Cloonan
President & CEO
Sionna Therapeutics
Jill Zunshine
Senior Vice President and Head of Global Real Estate, Facilities, and Procurement
Takeda
Courtney Thorne
Partner - Public Companies and Capital Markets
Cooley
Simon Read
CEO
Mariana Oncology
Donna Higgins
Founder & CEO
The Higgins Group, Inc.
James Ehret
Managing Director, Life Sciences
Banc of California
Parag Shah
Founding Managing Director & CEO
K2 HealthVentures
Andrew Miller
Founder & COO
Karuna Therapeutics
Christopher Viehbacher
President & CEO
Biogen
Dan Rosan
CBO & CFO
Ascidian Therapeutics
Brian Tobin
CEO
Tobin Scientific
Mark Mallon
CEO and Board Director
George Medicines
Tamar Thompson
Head, Global Corporate Affairs
Alexion Pharmaceuticals
Christine Brennan
Managing Director
Vertex Ventures
Reshma Kewalramani
CEO
Vertex Pharmaceuticals
Ellen Travers
Partner
Chartwell Partners
Christy Kahana
Founder & CEO
Claria Partners
Amy Atwood
VP, U.S. Business Unit and U.S. Region Communications & Philanthropy
Takeda
Nick Amarante
Executive Vice President & Boston Market Leader
Hughes Marino
Jessica Ballinger
President & CEO
Lyndra Therapeutics
Warren Browne
Founder & CEO
Browne Consulting Group
Bill Collins
Partner, Life Science Practice
Goodwin
Maia Harris
Troutman Pepper Hamilton Sanders LLP
Darrin Miles
CEO
Nested Therapeutics
Holly Reeves
Partner
PwC
Craig Hilts
Partner
WilmerHale
Stefan Spazek
Executive Vice President
Capital Advisors
Shirley Kuhlmann
EVP, General Counsel & Chief Administrative Officer
Collegium Pharmaceutical
Katherine Andersen
Head of Life Science & Healthcare
HSBC
Nathan Dowden
President & COO
Entrada Therapeutics
Joseph Goldberg
Partner, Strategy & Management Consulting
RSM US LLP
Keira Driansky
Executive Vice President, President of North America
Ipsen
Lyn Baranowski
Chief Executive Officer
Avalyn Pharma Inc.
Caren Deardorf
Chief Commercial & Strategy Officer
Editas Medicine
Irina Margine, Ph.D.
Biotech Sector Lead, Private Equity
Wellington Management
Brendan St. Amant
General Counsel & Corporate Secretary
Seismic Therapeutic
Mitch Perez
Vice President, Life Sciences
Cresa
Steven Favaloro
Chairman & CEO
Genezen